NCT07506382 Comparative Observational Study of Supra-annular Versus Intra-annular Self-expanding Aortic Valves in Routine Clinical Practice
| NCT ID | NCT07506382 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Montpellier |
| Condition | Trans-catheter Aortic Valve Implantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 419 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2028-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 419 participants in total. It began in 2026-02-10 with a primary completion date of 2028-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We proposed to compare in an observational study procedural success at one month (VARC 3 criteria) and clinical and echographic follow-up at 6 months between 2 self expandable devices in TAVR : the supra annular Evolut device (Medtronic) vs the intra anular NAVITOR device (Abott)
Eligibility Criteria
Inclusion Criteria: * all patients elligible for TAVR witn a self expandable device Exclusion Criteria: * femoral access not suitable * valve in valve procedures
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07506382 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Trans-catheter Aortic Valve Implantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07506382 currently recruiting?
Yes, NCT07506382 is actively recruiting participants. Contact the research team at f-leclercq@chu-montpellier.fr for enrollment information.
Where is the NCT07506382 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT07506382 clinical trial?
NCT07506382 is sponsored by University Hospital, Montpellier. The trial plans to enroll 419 participants.